India has officially approved and launched Mounjaro (tirzepatide), a groundbreaking injectable medication for the treatment of Type 2 diabetes and obesity. Developed by Eli Lilly and Company, the drug ...

In a bold move to address the growing epidemic of lifestyle diseases in India, Redial Clinic has launched a nationwide initiative focused on reversing type 2 diabetes, hypertension, and obesity ...

Health workers have long relied on Body Mass Index as a way to measure whether people are within a healthy weight range. Now, a collection of top researchers have made the case for a new way to ...

Dapagliflozin, a SGLT2 inhibitor used for type 2 diabetes, alleviates steatohepatitis and fibrosis in patients with ...

Gary Miller remembers being told by a [former] doctor that his fatty liver disease was a “benign condition.”“This doctor ...

Indian contract drug manufacturer OneSource Specialty Pharma expects strong growth in its order book over the next three years, driven by the global boom in weight-loss drugs, its top executive said ...

Last week, Australia’s Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnoea, a ...

A large European study found that consuming a greater variety of plant-based proteins, vegetables, and major food groups is linked to a lower risk of developing type 2 diabetes. The protective effect ...

Real-world results for blockbuster weight-loss meds like Ozempic, Wegovy and Zepbound aren't as impressive as those promised ...

A popular fat found in olive oil may not be as innocent as it seems. Scientists discovered that oleic acid, a major component of many high-fat foods, uniquely spurs the growth of new fat cells by ...

Novo Nordisk will pay U.S. biotech Deep Apple Therapeutics up to $812 million in a partnership deal aimed at developing drugs to treat cardiometabolic diseases, including obesity.

Though cardiovascular disease mortality rates remain high in the U.S., the tools and knowledge are in place to reverse trends ...